Skip to content | Change text size
 

Abeta peptide and Alzheimer's disease

Edited by Colin J. Barrow and David H. Small
Godalming, UK : Springer-verlag London, 2006

ISBN: 1852339616

Are you a Monash author?
If you are:
  • a member of the Monash community; and
  • have published, or are about to publish a book.
Let us know about it by
emailing: authors@monash.edu.au

 

Borrow it: Monash University Library members can borrow this book.  View the catalogue record for details.

Buy it: This book may be available from the Monash University Bookshop or purchased from amazon.com.

Book description
Recent advances in genetics and brain biochemistry point to the Abeta peptide as the major culprit in causing neurodegeneration in Alzheimer’s Disease (AD). Abeta Peptide and Alzheimer’s Disease is specifically targeted at summarizing current knowledge of the Abeta peptide and its role in AD.

Written by leaders in the industrial and academic world specializing in this rapidly moving area, the book covers fundamental biochemical studies on this peptide, the genetic impact on Abeta expression and processing, and various AD therapeutic strategies that target Abeta. Although specifically focusing on the Abeta peptide and AD, there is also some discussion on the similarity and differences of this peptide and AD with other amyloidogenic diseases, such as prion disease, Parkinsons and Huntingtons. This book will primarily be of interest to AD researchers and clinicians but also to researchers of other amyloid diseases. [Publisher's website]

About the author
Associate Professor David Small is a Senior Research Fellow in the Department of Biochemistry and Molecular Biology at Monash University.  He is the author of more than 110 publications in international refereed journals and 4 patents. He is on the editorial boards of several journals including Journal of Neurochemistry, Journal of Neuroscience Research, Journal of Alzheimer's Disease and Current Alzheimer's Research and is a member of the International Scientific Advisory Committee for Cholinesterase Conferences, a member of the Review Board of the Medical & Scientific Advisory Council of the Alzheimer's Association (USA).

Need help? Library frequently asked questions and online enquiries: current students/staff | public users, online chat, or phone +61 3 9905 5054
Something to say? Use our online enquiry service to send us your feedback and suggestions: current students/staff | public users